81 related articles for article (PubMed ID: 19563407)
1. Clinicopathological significance of DEK overexpression in serous ovarian tumors.
Han S; Xuan Y; Liu S; Zhang M; Jin D; Jin R; Lin Z
Pathol Int; 2009 Jul; 59(7):443-7. PubMed ID: 19563407
[TBL] [Abstract][Full Text] [Related]
2. Serous surface papillary borderline ovarian tumors: correlation of sonographic features with clinic pathological findings.
Wang D; Su N; Wang R; Zhang L; Qi Z; Liu Z; Yang J; Leng J; Xiang Y;
Ultrasound Obstet Gynecol; 2024 May; 63(5):691-698. PubMed ID: 37592848
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Review of Serous Tumors of Tubo-Ovarian Origin: Clinical Behavior, Pathological Correlation, Current Molecular Updates, and Imaging Manifestations.
Folsom SM; Berger J; Soong TR; Rangaswamy B
Curr Probl Diagn Radiol; 2023; 52(5):425-438. PubMed ID: 37286440
[TBL] [Abstract][Full Text] [Related]
4. Massive serous cyst adenoma with ovarian abscess causing fatal septicaemia.
Tambawala ZY; Saquib S; Shinko IA; Nagshabandi Z
BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37989331
[TBL] [Abstract][Full Text] [Related]
5. Expression of Toll-like receptor 4 in ovarian serous adenocarcinoma and correlation with clinical stage and pathological grade.
Luo XZ; He QZ; Wang K
Int J Clin Exp Med; 2015; 8(8):14323-7. PubMed ID: 26550417
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Serous Cystadenoma of the Epididymis: A Case Report.
Pierce DP; Chen B; Taylor L
Cureus; 2023 Oct; 15(10):e46886. PubMed ID: 37954785
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Potential Diagnostic Utility of the Determination of Selected Caspases-Markers Involved in the Regulation of Apoptosis-In Patients with Ovarian Cancer.
Mielczarek-Palacz A; Jasińska S; Strzelec A
Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33919909
[TBL] [Abstract][Full Text] [Related]
8. Ovarian Tumors.
Byford WH
Chic Med Exam; 1862 Feb; 3(2):65-88. PubMed ID: 37472791
[No Abstract] [Full Text] [Related]
9. Ovarian Tumors.
Byford WH
Chic Med Exam; 1862 Mar; 3(3):129-144. PubMed ID: 37472714
[No Abstract] [Full Text] [Related]
10. Clinical Potential of YY1-Hypoxia Axis for Vascular Normalization and to Improve Immunotherapy.
Meo C; de Nigris F
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339244
[TBL] [Abstract][Full Text] [Related]
11. Prognosis signature for predicting the survival and immunotherapy response in esophageal carcinoma based on cellular senescence-related genes.
Wang Y; Dai L; Huang R; Li W; Wu W
Front Oncol; 2023; 13():1203351. PubMed ID: 37664030
[TBL] [Abstract][Full Text] [Related]
12. Potential of
Habiburrahman M; Wardoyo MP; Sutopo S; Rahadiani N
Mol Clin Oncol; 2022 Jul; 17(1):117. PubMed ID: 35747597
[TBL] [Abstract][Full Text] [Related]
13. Long Non-Coding LEF1-AS1 Sponge miR-5100 Regulates Apoptosis and Autophagy in Gastric Cancer Cells via the miR-5100/DEK/AMPK-mTOR Axis.
Zhang H; Wang J; Wang Y; Li J; Zhao L; Zhang T; Liao X
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563178
[TBL] [Abstract][Full Text] [Related]
14. DEK overexpression is predictive of poor prognosis in esophageal squamous cell carcinoma.
Yi H; Duan H; Shi W; Liu Z; Liu Y
Arch Med Sci; 2021; 17(1):135-141. PubMed ID: 33488866
[TBL] [Abstract][Full Text] [Related]
15. Role of the DEK oncogene in the development of squamous cell carcinoma.
Ishida K; Nakashima T; Shibata T; Hara A; Tomita H
Int J Clin Oncol; 2020 Sep; 25(9):1563-1569. PubMed ID: 32656741
[TBL] [Abstract][Full Text] [Related]
16. The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress.
Ganz M; Vogel C; Czada C; Jörke V; Gwosch EC; Kleiner R; Pierzynska-Mach A; Zanacchi FC; Diaspro A; Kappes F; Bürkle A; Ferrando-May E
PLoS One; 2019; 14(8):e0213130. PubMed ID: 31408463
[TBL] [Abstract][Full Text] [Related]
17. Sex differences in DEK expression in the anterior cingulate cortex and its association with dementia severity in schizophrenia.
O'Donovan SM; Franco-Villanueva A; Ghisays V; Caldwell JL; Haroutunian V; Privette Vinnedge LM; McCullumsmith RE; Solomon MB
Schizophr Res; 2018 Dec; 202():188-194. PubMed ID: 30017458
[TBL] [Abstract][Full Text] [Related]
18. Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence.
Matrka MC; Cimperman KA; Haas SR; Guasch G; Ehrman LA; Waclaw RR; Komurov K; Lane A; Wikenheiser-Brokamp KA; Wells SI
PLoS Genet; 2018 Mar; 14(3):e1007227. PubMed ID: 29538372
[TBL] [Abstract][Full Text] [Related]
19. The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
Martinez-Useros J; Moreno I; Fernandez-Aceñero MJ; Rodriguez-Remirez M; Borrero-Palacios A; Cebrian A; Gomez Del Pulgar T; Del Puerto-Nevado L; Li W; Puime-Otin A; Perez N; Soengas MS; Garcia-Foncillas J
BMC Cancer; 2018 Feb; 18(1):144. PubMed ID: 29409457
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of DEK in human solid tumors: a meta-analysis.
Liu G; Xiong D; Zeng J; Xu G; Xiao R; Chen B; Huang Z
Oncotarget; 2017 Nov; 8(58):98985-98992. PubMed ID: 29228743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
